British Journal of Cancer - Table of Contents alert Volume 115 Issue 12

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 115, Issue 12 (1441-1583) Published online 6 December 2016 In this issue Editorial Commentary Minireviews Clinical Studies Translational Therapeutics Molecular Diagnostics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Blood Cancer Journal is an online-only, open access journal, publishing high quality research on hematologic malignancies and related disorders. Explore the benefits of submitting your next research article. Editorial Top Trastuzumab cardiotoxiciy: the age-old balance of risk and benefit Michael S Ewer and Steven M Ewer Br J Cancer 2016 115: 1441-1442; advance online publication, November 22, 2016; 10.1038/bjc.2016.381 Full Text Commentary Top A new roadmap to improve translation of imaging biomarkers Michael Skwarski and Geoff S Higgins Br J Cancer 2016 115: 1443-1444; advance online publication, November 15, 2016; 10.1038/bjc.2016.374 Full Text Minireviews Top Cell of origin of glioma: biological and clinical implications Sheila R Alcantara Llaguno and Luis F Parada Br J Cancer 2016 115: 1445-1450; advance online publication, November 10, 2016; 10.1038/bjc.2016.354 Abstract | Full Text The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug Francesca Sacco, Alberto Calderone, Luisa Castagnoli and Gianni Cesareni Br J Cancer 2016 115: 1451-1456; advance online publication, November 22, 2016; 10.1038/bjc.2016.385 Abstract | Full Text Clinical Studies Top Acute interstitial nephritis related to immune checkpoint inhibitors Julie Belliere, Nicolas Meyer, Julien Mazieres, Sylvie Ollier, Serge Boulinguez, Audrey Delas, David Ribes and Stanislas Faguer Br J Cancer 2016 115: 1457-1461; advance online publication, November 10, 2016; 10.1038/bjc.2016.358 Abstract | Full Text Trastuzumab-associated cardiac events in the Persephone trial Helena M Earl, Anne-Laure Vallier, Janet Dunn, Shrushma Loi, Emma Ogburn, Karen McAdam, Luke Hughes-Davies, Adrian Harnett, Jean Abraham, Andrew Wardley, David A Cameron, David Miles, Ioannis Gounaris, Chris Plummer and Louise Hiller Br J Cancer 2016 115: 1462-1470; advance online publication, November 22, 2016; 10.1038/bjc.2016.357 Abstract | Full Text The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients Matteo Lambertini, Ana Catarina Pinto, Lieveke Ameye, Lynn Jongen, Lucia Del Mastro, Fabio Puglisi, Francesca Poggio, Marta Bonotto, Giuseppe Floris, Kathleen Van Asten, Hans Wildiers, Patrick Neven, Evandro de Azambuja, Marianne Paesmans and Hatem A Azim Jr Br J Cancer 2016 115: 1471-1478; advance online publication, November 1, 2016; 10.1038/bjc.2016.359 Abstract | Full Text A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening Rosalind Raine, Sue M Moss, Christian von Wagner, Wendy Atkin, Ines Kralj Hans, Rosemary Howe, Francesca Solmi, Stephen Morris, Nicholas Counsell, Allan Hackshaw, Stephen Halloran, Graham Handley, Richard F Logan, Sandra Rainbow, Steve Smith, Julia Snowball, Helen Seaman, Mary Thomas, Samuel G Smith, Lesley M McGregor, Gemma Vart, Jane Wardle and Stephen W Duffy Br J Cancer 2016 115: 1479-1486; advance online publication, November 22, 2016; 10.1038/bjc.2016.365 Abstract | Full Text Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial Andrew J Coldman, Lovedeep Gondara, Laurie W Smith, Dirk van Niekerk, Kathy Ceballos, Mel Krajden, Darrel Cook, David J Quinlan, Marette Lee, Gavin CE Stuart, Stuart Peacock, Ruth Elwood Martin, Laura Gentile, Eduardo L Franco and Gina S Ogilvie Br J Cancer 2016 115: 1487-1494; advance online publication, November 17, 2016; 10.1038/bjc.2016.368 Abstract | Full Text Determining cancer survivors' preferences to inform new models of follow-up care Peter Murchie, Patricia F Norwood, Marta Pietrucin-Materek, Terry Porteous, Philip C Hannaford and Mandy Ryan Br J Cancer 2016 115: 1495-1503; advance online publication, November 1, 2016; 10.1038/bjc.2016.352 Abstract | Full Text Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment J L Kuiper, S M S Hashemi, E Thunnissen, P J F Snijders, K Grünberg, E Bloemena, D Sie, P E Postmus, D A M Heideman and E F Smit Br J Cancer 2016 115: 1504-1512; advance online publication, November 22, 2016; 10.1038/bjc.2016.372 Abstract | Full Text Translational Therapeutics Top An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy Lishuang Qi, Yang Li, Yuan Qin, Gengen Shi, Tianhao Li, Jiasheng Wang, Libin Chen, Yunyan Gu, Wenyuan Zhao and Zheng Guo Br J Cancer 2016 115: 1513-1519; advance online publication, November 17, 2016; 10.1038/bjc.2016.370 Abstract | Full Text Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials Steffen Ormanns, Michael Haas, Sibylle Baechmann, Annelore Altendorf-Hofmann, Anna Remold, Detlef Quietzsch, Michael R Clemens, Martin Bentz, Michael Geissler, Helmut Lambertz, Stephan Kruger, Thomas Kirchner, Volker Heinemann and Stefan Boeck Br J Cancer 2016 115: 1520-1529; advance online publication, November 1, 2016; 10.1038/bjc.2016.355 Abstract | Full Text Molecular Diagnostics Top Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer A Kenneth MacLeod, Lourdes Acosta-Jimenez, Philip J Coates, Michael McMahon, Frank A Carey, Tadashi Honda, Colin J Henderson and C Roland Wolf Br J Cancer 2016 115: 1530-1539; advance online publication, November 8, 2016; 10.1038/bjc.2016.363 Abstract | Full Text Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours Alexa Childs, Clare Vesely, Leah Ensell, Helen Lowe, Tu Vinh Luong, Martyn E Caplin, Christos Toumpanakis, Christina Thirlwell, John A Hartley and Tim Meyer Br J Cancer 2016 115: 1540-1547; advance online publication, November 22, 2016; 10.1038/bjc.2016.377 Abstract | Full Text miR-146a-5p mediates epithelial–mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2 Cong Wang, Wenxue Zhang, Lin Zhang, Xuan Chen, Fang Liu, Jing Zhang, Shanghui Guan, Yi Sun, Pengxiang Chen, Ding Wang, Effat Un Nesa, Yufeng Cheng and George M Yousef Br J Cancer 2016 115: 1548-1554; advance online publication, November 10, 2016; 10.1038/bjc.2016.367 Abstract | Full Text A protein fragment derived from DNA-topoisomerase I as a novel tumour-associated antigen for the detection of early stage carcinoma Shang-mian Yie, Shang-rong Ye, Xiao-li Ma, Ke Xie, Jian-bo Zhang, Mei Cao, Xu He, Zhen-bo Hu, Cheng-lu Yang, Jia Zhang and Jie Zeng Br J Cancer 2016 115: 1555-1564; advance online publication, November 22, 2016; 10.1038/bjc.2016.369 Abstract | Full Text Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence Sjoerd H den Uil, Veerle M H Coupé, Janneke F Linnekamp, Evert van den Broek, Jeroen A C M Goos, Pien M Delis-van Diemen, Eric J Th Belt, Nicole C T van Grieken, Patricia M Scott, Louis Vermeulen, Jan Paul Medema, Herman Bril, Hein B A C Stockmann, Robert T Cormier, Gerrit A Meijer and Remond J A Fijneman Br J Cancer 2016 115: 1565-1574; advance online publication, November 17, 2016; 10.1038/bjc.2016.376 Abstract | Full Text Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study Sanne Samuels, Balazs Balint, Heiko von der Leyen, Philippe Hupé, Leanne de Koning, Choumouss Kamoun, Windy Luscap-Rondof, Ulrike Wittkop, Ksenia Bagrintseva, Marina Popovic, Atttila Kereszt, Els Berns, Gemma G Kenter, Ekaterina S Jordanova, Maud Kamal and Susy Scholl Br J Cancer 2016 115: 1575-1583; advance online publication, November 22, 2016; 10.1038/bjc.2016.340 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.